- Poster presentation
- Open Access
Multidrug resistance among P. aeruginosa and Enterobacteriaceae in US hospitals, 2000 to 2009
Critical Care volume 17, Article number: P75 (2013)
Gram-negative resistance remains a major challenge in the care of critically ill patients. Traditionally, P. aeruginosa (PA) has represented the most concerning pathogen. However, carbapenemase-producing Enterobacteriaceae (CPE) have emerged as a challenge, but the epidemiology of this pathogen is poorly understood.
We analyzed a large US-based microbiology database, Eurofins TSN, between the years 2000 and 2009. We aimed to describe the prevalence of infection with either multidrug-resistant (MDR) PA or CPE. We defined MDR-PA as any PA isolate resistant to ≥3 drug classes. Enterobacteriaceae were classified as CPE if resistant to both a third-generation cephalosporin and a carbapenem. We evaluated specimens from respiratory, bloodstream, urinary tract (UTI) and complicated intra-abdominal infections.
We identified 327,912 PA (60,695 (18.5%) MDR-PA) and 279,600 Enterobacteriaceae (2,558 (0.9%) CPE) specimens. More than one-quarter (26.1%) of all PA were recovered from ICU patients as compared with 17.9% of all Enterobacteriaceae specimens. Of those specimens originating in the ICU, MDR-PA represented 21.9% of all PA organisms, while CPE represented 1.6% of all Enterobacteriaceae. Pneumonia and UTI accounted for 92.4% of all PA and 84.0% of all Enterobacteriaceae specimens. The proportion of both MDR-PA and CPE was highest in pneumonia (22.0% and 1.6%, respectively) and lowest in UTI (13.7% and 0.6%, respectively). Over the time frame of the study, CPEs emerged and stabilized at approximately 2.8% of all Enterobacteriaceae, while MDR-PA increased slightly from 16.0% of all PA in 2000 to 17.8% in 2009.
Although CPE organisms have emerged as an important pathogen, MDR-PA remains an order of magnitude more prevalent in the United States. Pneumonia patients and those in the ICU are at an increased risk for both MDR-PA and CPE infections compared with those outside the ICU.
About this article
Cite this article
Zilberberg, M., Shorr, A. Multidrug resistance among P. aeruginosa and Enterobacteriaceae in US hospitals, 2000 to 2009. Crit Care 17, P75 (2013). https://doi.org/10.1186/cc12013
- Public Health
- Urinary Tract
- Time Frame
- Emergency Medicine